May 09, 2017 20:06 pm UTC| Business
- First Quarter GAAP Revenues of $90 million, non-GAAP Revenues of $95 million -- Company Announces Implementation of Strategic Initiatives to Drive Portfolio Growth -- 2017 Non-GAAP Revenue Guidance of $410 to $430...
May 09, 2017 20:06 pm UTC| Business
- First Quarter GAAP Revenues of $90 million, non-GAAP Revenues of $95 million -- Company Announces Implementation of Strategic Initiatives to Drive Portfolio Growth -- 2017 Non-GAAP Revenue Guidance of $410 to $430...
May 09, 2017 20:06 pm UTC| Business
- First Quarter GAAP Revenues of $90 million, non-GAAP Revenues of $95 million -- Company Announces Implementation of Strategic Initiatives to Drive Portfolio Growth -- 2017 Non-GAAP Revenue Guidance of $410 to $430...
May 09, 2017 20:06 pm UTC| Business
- First Quarter GAAP Revenues of $90 million, non-GAAP Revenues of $95 million -- Company Announces Implementation of Strategic Initiatives to Drive Portfolio Growth -- 2017 Non-GAAP Revenue Guidance of $410 to $430...
FibroGen Reports First Quarter 2017 Financial Results
May 09, 2017 20:05 pm UTC| Business
SAN FRANCISCO, May 09, 2017 -- FibroGen, Inc. (NASDAQ:FGEN), a science-based biopharmaceutical company, today reported financial results for the first quarter of 2017 and provided an update on the company’s recent...
FibroGen Reports First Quarter 2017 Financial Results
May 09, 2017 20:05 pm UTC| Business
SAN FRANCISCO, May 09, 2017 -- FibroGen, Inc. (NASDAQ:FGEN), a science-based biopharmaceutical company, today reported financial results for the first quarter of 2017 and provided an update on the company’s recent...
FibroGen Reports First Quarter 2017 Financial Results
May 09, 2017 20:05 pm UTC| Business
SAN FRANCISCO, May 09, 2017 -- FibroGen, Inc. (NASDAQ:FGEN), a science-based biopharmaceutical company, today reported financial results for the first quarter of 2017 and provided an update on the company’s recent...